Puma VCT 13 plc Surpasses £50 Million Target with Oversubscribed Share Offer Closing on 25 August 2026

Puma VCT 13 plc’s Share Offer Exceeds Initial Capital Target Through Oversubscription

Launched on 24 September 2025, Puma VCT 13 plc’s subscription offer aimed to raise up to £50 million by issuing new ordinary shares with a nominal value of £0.0005 each. The offer included an over-allotment facility permitting an additional £20 million to be raised if investor demand justified expansion. This structure allowed the company to capitalise on strong market interest while maintaining a clear initial fundraising goal.

By 23 July 2026, Puma VCT 13 had secured gross proceeds exceeding £53.5 million, indicating that the initial £50 million target was met and the £20 million over-allotment fully exercised. This oversubscription highlights strong investor confidence in the venture capital trust’s investment approach and management team. The rapid utilisation of the over-allotment facility marks a significant milestone in the fundraising campaign.

Offer Closure and Final Allotment Schedule for Puma VCT 13

The subscription offer officially closed at 5.00 pm on 25 August 2026, marking the end of the period for new investors to subscribe. The Directors have the authority to advance the closing date if deemed appropriate, with any changes communicated through formal market announcements to ensure transparency.

Following closure, the final allotment of shares is planned for on or around 28 August 2026. Admission to trading is expected within two business days of allotment, likely occurring in early September 2026. This schedule provides clarity for subscribers regarding share ownership and the commencement of trading on the relevant market.

Venture Capital Trust Structure and Investment Strategy

Puma VCT 13 plc operates as a venture capital trust (VCT), a UK-regulated investment vehicle focused on investing in unquoted companies. VCTs aim to generate returns through capital growth and dividends while offering investors potential tax benefits under HMRC rules. This structure appeals to UK retail investors seeking long-term exposure to emerging and smaller companies.

The fundraising via new share issuance follows the standard VCT model, with shares issued at a nominal value of £0.0005 each. The actual subscription price was set according to the prospectus published on 24 September 2025. The inclusion of an over-allotment facility underscores the company’s intent to maximise capital raised for investment deployment.

Investor Demand and Oversubscription Implications

The gross proceeds exceeding £53.5 million by 23 July 2026, surpassing the £50 million base target plus the £20 million over-allotment, reflect robust investor demand for Puma VCT 13’s offering. Full utilisation of the over-allotment facility indicates significant interest beyond the initial target, demonstrating market confidence in the trust’s strategy and management.

Such oversubscription often signals positive attributes including strong management reputation, clear investment strategy, attractive fee arrangements, and favourable market conditions for venture capital investments. For current and prospective shareholders, this level of demand typically supports share price performance and market liquidity once trading begins.

Regulatory Compliance and Admission Process

The offer was conducted under the terms of a prospectus published on 24 September 2025, detailing investment objectives, management, fees, risks, and offer conditions. This ensures compliance with UK financial services and securities regulations.

The timeline—closing on 25 August 2026, allotment around 28 August 2026, and trading admission within two business days—aligns with standard market practices for VCT offerings. Admission confirms that shares are registered and eligible for trading, providing liquidity to investors.

Directors’ Authority to Expedite Offer Closure

The Directors retain discretion to bring forward the closing date if all shares under the over-allotment facility are committed or if market conditions warrant an earlier close. Any such decision will be promptly announced to maintain transparency and inform all market participants.

Capital Deployment and Investment Focus Post-Offer

With gross proceeds exceeding £53.5 million, Puma VCT 13 will invest in accordance with VCT qualifying criteria, typically targeting unquoted or early-stage companies. Detailed investment strategies, sector focuses, and target sizes are outlined in the prospectus.

The sizeable capital raised enables the company to pursue its investment objectives effectively. Updates on capital deployment, portfolio performance, and progress will be communicated regularly to shareholders through formal reporting channels.

Trading Admission and Share Liquidity Outlook

Following allotment, Puma VCT 13 shares will be tradable on the relevant market, allowing shareholders to buy and sell their holdings. While trading liquidity can vary, the shares’ admission facilitates market participation and price discovery.

Investors should note that VCTs are long-term investments with underlying illiquid assets. Share prices may fluctuate based on portfolio valuation, dividend prospects, market sentiment, and economic factors. New investors should anticipate holding shares over a medium to long-term horizon.

Market Environment and VCT Sector Overview

Puma VCT 13’s successful capital raise occurs within the established UK VCT sector, which supports investment in smaller and emerging companies through tax-advantaged structures. The company’s ability to exceed its target reflects sustained investor interest despite evolving regulatory and fiscal conditions.

This fundraising completion transitions Puma VCT 13 from capital raising to investment deployment, aiming to build a diversified portfolio capable of delivering returns over time. The trust’s performance will be monitored relative to peers by investors and analysts.

Shareholder Communications and Ongoing Reporting

Post-offer, Puma VCT 13 will adhere to ongoing disclosure and reporting requirements applicable to listed VCTs. Shareholders will receive updates on financial results, portfolio status, and management commentary through statutory reports and regulatory filings.

Investors are encouraged to review the prospectus and disclosures to understand the investment approach, fees, risks, and expected returns. For further information, contact Eliot Kaye at 020 7408 4050. Shareholders should stay informed via official market announcements.